cannabidiolic acid has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, TA; Farley, S; Leier, HC; Muchiri, RN; Tafesse, FG; van Breemen, RB; Weinstein, JB | 1 |
| Anceschi, L; Brighenti, V; Gallinella, G; Governa, P; Manetti, F; Morellini, A; Pellati, F; Pollastro, F; Rossini, G; Salamone, S; Tamburello, M | 1 |
2 other study(ies) available for cannabidiolic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Benzoates; Cannabinoids; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Humans; Ligands; Mass Spectrometry; Models, Molecular; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Internalization | 2022 |
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2.
Topics: Cannabinoids; Cannabis; COVID-19; COVID-19 Drug Treatment; SARS-CoV-2 | 2023 |